In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease
Rabea Asleh, Andrew P LevyFaculty of Medicine, Technion-Israel Institute of Technology, Haifa, IsraelAbstract: Hemoglobin (Hb) released during hemolysis is a potent oxidant. Extracorpuscular Hb may enter the vessel wall and mediate low-density lipoprotein oxidation, thereby promoting the development...
Main Authors: | Rabea Asleh, Andrew P Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2005-04-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/in-vivo-and-in-vitro-studies-establishing-haptoglobin-as-a-major-susce-peer-reviewed-article-VHRM |
Similar Items
-
The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and Mice
by: Inbal Dahan, et al.
Published: (2018-01-01) -
The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes
by: Shmuel Somer, et al.
Published: (2021-12-01) -
Changing the Face of Diabetic Care with Haptoglobin Genotype Selection and Vitamin E
by: Nina S. Levy, et al.
Published: (2011-04-01) -
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation
by: Asleh R, et al.
Published: (2018-04-01) -
Haptoglobins and hemoglobin-haptoglobin complexes
by: Malchy, Barry L.
Published: (2011)